Pfizer announced on Monday that Patrizia Cavazzoni, the former head of the U.S. Food and Drug Administration’s drug evaluation unit, has been named its new Chief Medical Officer.
Cavazzoni, an industry veteran, will oversee Pfizer’s regulatory and drug safety operations, bringing a wealth of experience to the role. Her appointment is seen as a strategic move to strengthen Pfizer’s leadership in navigating complex regulatory environments and ensuring the safety and efficacy of its medicines.
